Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

Incyte (INCY) Outperforms Industry YTD: What Lies Ahead?

Image sourced from Shutterstock

Benzinga

Why Is Canoo Surging By 80%? 52 Stocks Moving In Tuesday's Mid-Day Session

Gainers

Benzinga

The scoop on microwaves: myth versus fact about this kitchen staple

Contrary to the belief that microwaves cook from the inside out, they actually heat the outer layers, which transfer heat to the inner portions.

Chicago Sun-Times

From analysis to the latest developments in health,
read the most diverse news in one place.

Pig organ transplants inch closer with testing in the dead

Researchers at New York University transplanted pig hearts into two brain-dead people over the last month, the latest in a string of developments in the long quest to one day save human lives with animal organs

The Independent UK

States Must Allow Abortions When Woman's Health or Life Is Threatened, Says HHS

Plus: When "anti-wokeness" becomes an obsession, why immigrants are upwardly mobile, and more...

Reason

Akanda To Supply Tetra Bio-Pharma With Cannabis For FDA Trials Of Cancer-Pain Drug

Akanda Corp.

Benzinga

The Daily Biotech Pulse: GSK To Supply 50M Flu Vaccine Doses To US, FDA Lifts Hold On Greenwich's Cancer Immunotherapy Trial, Connect Biopharma Sees CBP-201 Topline Data Sooner

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Is Biotech Ready for Another Bull Run? 3 Stocks to Get in Ahead of the Crowd

The biotech industry flourished during the height of the COVID-19 pandemic and reported record revenues and earnings last year. Despite the market slowdown, the sector is poised for another bull run, given the continued global fight against COVID-19 and the increasing demand with an aging population. Popular biotech stocks Pfizer…

StockNews.com

Alibaba, Zoom Video And 76 Biggest Movers From Yesterday

Gainers Kaspien Holdings Inc. (NASDAQ: KSPN) shares climbed 161.9% to close at $6.81 on Monday on heavy volume amid mention of the stock on social media.

Benzinga

The FDA Will Consider Whether To Approve a Birth Control Pill for Over-the-Counter Use

If approved, the drug could increase access to effective birth control.

Reason

FDA could approve over-the-counter purchase of first birth control pill

The agency is considering the application by HRA Pharma to make Opill available without a prescription

The Guardian - US

Why These Casino Stocks Are Moving Lower, Here's 45 Stocks Moving In Monday's Mid-Day Session

Gainers Pliant Therapeutics, Inc. (NASDAQ: PLRX) jumped 112.6% to $18.88 after the company said its treatment for Idiopathic Pulmonary Fibrosis was well tolerated in a Phase 2a study.

Benzinga

When it comes to darker skin, pulse oximeters fall short

These devices measure blood oxygen levels and can help identify when patients are dangerously ill. But research shows they can deliver misleading results for people with darker skin.

WEKU

Widely used hospital gowns show signs of exposing workers to infection

Disposable gowns designed to deflect the splatter of bodily fluids, used in thousands of U.S. hospitals, have underperformed in recent and ongoing laboratory tests and may fall short of safety standards, leaving health care workers with a greater risk of infection than advertised.

Tribune News Service

Get all your
news in one place.

100's of premium titles.
One news app.

Axios

FDA to consider application for first over-the-counter birth control pill

"This historic application marks a groundbreaking moment in contraceptive access and reproductive equity."

The Independent UK

Over-the-counter birth control? Drugmaker seeks FDA approval

A drug company is seeking U.S. approval for the first birth control pill that women could buy without a prescription

Tribune News Service

Ask the Pediatrician: What should parents know about COVID-19 vaccine for children under 5?

Q: I have heard that there’s an approved COVID-19 vaccine for children under 5. What do I need to know about it?

The Guardian - US

Hopes US baby formula shortage could ease as key Abbott plant restarts

Factory in Sturgis, Michigan shut down in May after storms that produced torrential flooding

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Production resumes at troubled Abbott baby formula factory

Abbot Nutrition says baby formula production has resumed at the Michigan plant whose February shutdown over contamination contributed to a national shortage

Bangkok Post

Certificates issued to almost 1m people wanting to grow cannabis

The Food and Drug Administration (FDA) has issued almost 1 million electronic certificates to registrants who seek permission to cultivate cannabis following the legalisation of cannabis and hemp on June 9.

Salon

Recall alert: Do you use this dog food?

Here's everything you need to know to keep your best friend safe

Benzinga

ATE.TO: Phase 2 Post-Operative Pain Program to Initiate in Calendar 4Q22…

By David Bautz, PhD OTC:ATBPF | TSX:ATE.TO READ THE FULL ATE.TO RESEARCH REPORT

The Guardian - US

Biden signs executive order to protect US abortion access and urges Americans to ‘vote, vote, vote’ – as it happened

US president says electing senators who would help codify Roe v Wade is the ‘fastest route’ to solidifying federal abortion rights – follow the latest

Reason

The Food & Drug Administration Has a Vaping Problem

Something is wrong at the Food & Drug Administration's Center for Tobacco Products, and federal courts are beginning to notice.

StockNews.com

This Biotech Stock Looks Like a Prime Growth Play

Diversified healthcare company Abbott (ABT) has demonstrated significant innovations across its segments, and given its dominant market position, the company’s prospects look bright. The stock could be a solid choice as it is well-positioned to survive short-term market fluctuations. Let’s discuss this in detail….

1 … 203 204 205 206

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.